ABBY NASTERNAK: Open Payments
NPI 1689645467 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,002 in 14 payments from 7 companies in 2025. Trend: 2023 $1,126 · 2024 $579 · 2025 $1,002
Food & beverage: $1,002
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 4 | $462 |
| ABBVIE INC. | 1 | $126 |
| Madrigal Pharmaceuticals | 1 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $104 |
| Gilead Sciences, Inc. | 5 | $96 |
| Lilly USA, LLC | 1 | $94 |
| Novo Nordisk Inc | 1 | $14 |
Products named: DAXXIFY, DAXI, SKYRIZI, REZDIFFRA, ENTYVIO, ZEPBOUND, Ozempic.
Industry payments across AZ — which companies pay providers there.
